Results 91 to 100 of about 48,960 (277)

Patient Characteristics and Outcomes of Endoscopically Placed Dedicated Transgastric Jejunal Tubes Compared to Percutaneous Endoscopic Gastrostomy With Jejunal Extension Tubes

open access: yesDEN Open, Volume 6, Issue 1, April 2026.
ABSTRACT Objectives Patients requiring long‐term enteral nutrition or continuous infusion of carbidopa/levodopa can benefit from jejunostomy tube placement. Recently, directly placed percutaneous transgastric jejunal tubes (TGJs) have been used instead of gastrostomy tubes with jejunal extensions (PEG‐Js) for enteral access.
Laura D. Kek   +7 more
wiley   +1 more source

Pneumatose kystique iléale révélée par un volvulus du grêle [PDF]

open access: yesThe Pan African Medical Journal, 2010
La pneumatose kystique intestinale est une pathologie rare qui se caractérise par la présence de kystes gazeux dans la paroi intestinale. Elle est asymptomatique ou pauci symptomatique, et le plus souvent découverte lors d’un examen d’imagerie ou d ...
Khalid Aït Taleb   +5 more
doaj  

Modelling the elimination of river blindness using long-term epidemiological and programmatic data from Mali and Senegal [PDF]

open access: yes, 2017
The onchocerciasis transmission models EPIONCHO and ONCHOSIM have been independently developed and used to explore the feasibility of eliminating onchocerciasis from Africa with mass (annual or biannual) distribution of ivermectin within the timeframes ...
Basáñez, M-G   +7 more
core   +7 more sources

The Influence of Bromelain Administration on Pro‐Inflammatory Cytokines and Lipid Peroxidation in a Rat Model of Intestinal Ischemia/Reperfusion Injury

open access: yesVeterinary Medicine and Science, Volume 12, Issue 2, March 2026.
Bromelain reduces levels of the pro‐inflammatory cytokines TNF‐α, IL‐1β and MDA in intestinal ischemia‐reperfusion injury. Bromelain's effects on cytokines also reduce damage to intestinal tissue.2 ABSTRACT Background Ischemia‐reperfusion injury is a critical problem that can occur following multiple clinical procedures.
Çağrı Gültekin   +3 more
wiley   +1 more source

Pharmacokinetics, safety, and efficacy of a single co-administered dose of diethylcarbamazine, albendazole and ivermectin in adults with and without Wuchereria bancrofti infection in Cote d\u27Ivoire [PDF]

open access: yes, 2019
BackgroundA single co-administered dose of ivermectin (IVM) plus diethylcarbamazine (DEC) plus albendazole (ALB), or triple-drug therapy, was recently found to be more effective for clearing microfilariae (Mf) than standard DEC plus ALB currently used ...
Bjerum, Catherine M   +9 more
core   +4 more sources

Chylous Mesenteric Cyst: A Rare Surgical Entity—A Case Report From Nepal

open access: yesClinical Case Reports, Volume 14, Issue 2, February 2026.
ABSTRACT Chylous Mesenteric Cyst is an uncommon benign abdominal cyst that can arise anywhere along the mesentery of the gastrointestinal tract, from the duodenum to the rectum. It is often asymptomatic but can rarely present with abdominal discomfort or a palpable abdominal mass. Final diagnosis typically relies on histopathology examination following
Ashwini Gurung, Alisha Rai, Arbin Joshi
wiley   +1 more source

Volvulus of the Gallbladder: A Case Report and Review of Literatures

open access: yesSiriraj Medical Journal, 2007
Objective: To report a case of volvulus of the gallbladder, the result of the treatment and a review of the literatures. Methods: Report a case of volvulus of the gallbladder and review literatures.
Aree Sontisirikit
doaj  

Comparison of Structural Changes in Nodding Syndrome and Other Epilepsies Associated With Onchocerca volvulus [PDF]

open access: gold, 2022
Rajarshi Mazumder   +13 more
openalex   +1 more source

Current status of intestinal transplantation in children [PDF]

open access: yes, 1998
Purpose: A clinical trial of intestinal transplantation (Itx) under tacrolimus and prednisone immunosuppression was initiated in June 1990 in children with irreversible intestinal failure and who were dependent on total parenteral nutrition (TPN ...
Asfar   +52 more
core   +1 more source

Home - About - Disclaimer - Privacy